enVVeno Medical (NVNO) Equity Average (2018 - 2020)

enVVeno Medical has reported Equity Average over the past 3 years, most recently at $2.6 million for Q3 2020.

  • Quarterly results put Equity Average at $2.6 million for Q3 2020, down 33.24% from a year ago — trailing twelve months through Sep 2020 was $2.6 million (down 33.24% YoY), and the annual figure for FY2019 was $1.5 million, up 133.28%.
  • Equity Average for Q3 2020 was $2.6 million at enVVeno Medical, up from $177411.5 in the prior quarter.
  • Over the last five years, Equity Average for NVNO hit a ceiling of $4.1 million in Q3 2018 and a floor of -$13.4 million in Q1 2018.
  • Median Equity Average over the past 3 years was $2.5 million (2019), compared with a mean of $293365.1.
  • Biggest five-year swings in Equity Average: skyrocketed 167.54% in 2019 and later plummeted 95.28% in 2020.
  • enVVeno Medical's Equity Average stood at $2.8 million in 2018, then fell by 26.98% to $2.0 million in 2019, then rose by 26.77% to $2.6 million in 2020.
  • The last three reported values for Equity Average were $2.6 million (Q3 2020), $177411.5 (Q2 2020), and $487658.5 (Q1 2020) per Business Quant data.